company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5682000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5682000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,241000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,159000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5840000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11122000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11122000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-49000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,245000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,196000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,196000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,16000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,16000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,16000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q1,2013-01-01,2013-03-31,2014-06-20 17:00:38+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10913000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5147000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5147000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,232000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,174000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4656000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9397000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9397000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-43000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3185000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3142000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3142000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6259000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5909000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5909000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,235000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,143000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1943000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7474000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7474000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1455000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,119000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1551000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1551000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5917000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3875000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3875000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,227000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,142000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4633000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8139000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8139000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-78000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,735000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,657000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,657000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,48000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-16000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,32000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,32000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,13000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7437000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5395000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5395000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,188000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,148000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4495000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9554000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9554000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-756000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,34000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-722000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-722000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,7000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q1,2014-01-01,2014-03-31,2014-06-20 17:00:38+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10289000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7401000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7401000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,167000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,240000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6623000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13617000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13617000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-292000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10045000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10337000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10337000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,756000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,80547000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-34000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,81269000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,81269000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,57319000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,28646000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,28646000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,172000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,370000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-41633000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12445000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12445000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-96000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-97000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-97000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-154000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-154000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-154000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-8000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12704000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6942000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6942000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,174000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,494000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5767000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12041000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12041000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-241000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-999000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1960000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,720000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,720000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,589000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,589000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-26000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10758000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14653000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14653000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,195000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,912000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2503000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16049000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16049000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-375000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12750000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1475000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11650000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11650000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-36000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,190792000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,190828000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,190828000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-14000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 16:02:33+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,163115000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17655000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17655000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,190000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1396000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2365000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18434000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18434000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-271000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7000000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6915000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-356000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-356000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,216860000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,216860000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,216860000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-14000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,198056000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26997000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26997000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,186000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1825000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4903000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20083000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20083000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-76000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-160750000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6965000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-153861000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-153861000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-23000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-23000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-23000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,8000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-173959000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26165000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26165000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,180000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2023000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2705000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26667000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26667000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-501000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5129000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4230000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1400000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1400000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,541000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,541000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,541000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,20000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-27506000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33363000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33363000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,235000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3037000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2810000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27281000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27281000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-931000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6566000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,5000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6250000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1242000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1242000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,45000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,45000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,45000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,21000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:01:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28457000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38866000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38866000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,270000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2326000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-465000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-36735000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-36735000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2022000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49047000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4000000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-47069000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-47069000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,135850000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-45000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,135805000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,135805000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,52001000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35134000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35134000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,509000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3762000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13276000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-44139000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-44139000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2609000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-78413000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,65445000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15577000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15577000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,312000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,312000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,312000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-59404000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48891000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-48891000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,660000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4374000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7675000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-51532000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-51532000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1057000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-31845000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,29070000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3832000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3832000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,948000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,948000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,948000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-21000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-54437000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-100328000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-100328000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,747000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5508000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,32674000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-61399000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-61399000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-849000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28334000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,54008000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,24825000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,24825000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,71000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,71000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,71000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:48+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-36503000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-74629000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-74629000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,739000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5972000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3063000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-64855000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-64855000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-677000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,112965000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,112288000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,112288000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,643000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,643000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,643000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,48076000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59565000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59565000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,752000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5862000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8114000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-44837000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-44837000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-470000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-215488000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,68768000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-147190000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-147190000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,162286000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-714000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,161572000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,161572000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-30455000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54357000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54357000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,763000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5632000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7564000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-55526000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-55526000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-54000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-61718000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,106229000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,44457000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,44457000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,631000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,631000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,631000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10438000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-87031000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-87031000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,801000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7252000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4883000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-74095000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-74095000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-212000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-415203000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,239184000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-176231000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-176231000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,277656000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,97710000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,20000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,375386000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,375386000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:01:48+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,125060000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-68389000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-68389000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,807000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10728000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4423000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-52431000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-52431000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-65000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-71828000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37000000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-34893000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-34893000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1122000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1122000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1122000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-86202000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-60920000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-60920000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,537000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8628000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,281000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-51474000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-51474000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1060000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35764000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,66629000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,29805000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,29805000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1467000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1142000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,325000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,325000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-21344000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3594000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-80089000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-80089000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,422000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8146000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1329000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-72850000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-72850000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1799000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,62000000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,60201000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,60201000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1104000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1104000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1104000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11545000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-117934000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-117934000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,533000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9576000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,33249000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-74576000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-74576000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-303000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-64022000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,36290000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-28035000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-28035000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,0.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,159307000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,430000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,159737000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,159737000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,57126000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q1,2019-01-01,2019-03-31,2019-05-02 16:07:13+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,3594000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-58411000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-58411000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,537000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14035000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15459000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-59298000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-59298000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-736000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,29000000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,28264000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,28264000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1192000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-430000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,762000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,762000.0
Alder Biopharmaceuticals Inc,ALDR,,0001423824,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-30272000.0
